chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Viral infection
Clinical narrative: Information has been received from a physician concerning a 1-year-old female who, "recently", in approximately 2005, was vaccinated with a dose of varicella virus vaccine live. Three weeks post vaccination", in approximately 2005, the patient experienced shingles that appeared on her arm and torso. Subsequently, the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Information has been received from a physician and a woman in the physician's office concerning an 8-year-old male who on 29-MAR-2000, at 3 years of age, was vaccinated with a first 0.5 mL dose of varicella virus vaccine live (Lot #632276/1454J). There was no concomitant therapy or illness at the time of vaccination. The physician reported that on 12-SEP-2005, the patient developed breakthrough chickenpox characterized by approximately 200-250 small lesions. Unspecified medical attention was sought. In September 2005, the patient's breakthrough chickenpox resolved. Additional information is not expected.
Age: 1.11
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Infection, Rash
Clinical narrative: Information has been received from a certified medical assistant (CMA) concerning a 13-month-old white female with no medical history or allergies who on 09-SEP-2005, was vaccinated in the left leg with the first 0.5 mL dose of varicella virus vaccine live (Lot #650222/0425R). Concomitant vaccinations on that same day included a 0.5 mL dose in the right leg of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (Lot #648665/0993P). The CMA reported that on 18-SEP-2005, the patient developed a rash over her entire body except for her mouth and eyes. On 20-SEP-2005, the patient presented to the physician's office with chickenpox characterized by about 50 red spots all over her body. The patient was noted to be afebrile and no laboratory/diagnostic tests were performed. The patient was treated with hydroxyzine HCl (ATARAX) and cephalexin (KEFLEX). In September 2005, a few days after onset, the patient's chickenpox resolved. Additional information is not expected.
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a pharmacist concerning an adult male who in approximately 2003 was vaccinated with a 0.5 mL second dose in the right thigh of varicella virus vaccine live. On 20-SEP-2005 a varicella titer was drawn that did not show seroconversion. It was reported that the patient had no symptoms. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Viral infection
Clinical narrative: Information has been received from a physician and a registered nurse concerning a 15-year-old white female, with no drug allergies and a history of ureteric vesicle reflux, hydronephrosis, chronic pyelonephritis, and ureteric re-implantation who on 22-AUG-2005 was in the left arm vaccinated with the first dose of varicella virus vaccine live (Lot # 648082/0216R). There was no concomitant therapy. The physician reported that on 01-SEP-2005, the patient developed 20-24 chickenpox with fever. On 15-SEP-2005, the patient presented to the physician's office with many lesions and was reported to be uncomfortable. Treatment was unknown and no laboratory/diagnostic tests were performed. subsequently, the patient's chickenpox resolved. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Medication error
Clinical narrative: Information has been received from a nurse practitioner concerning a 5 yr old male who was vaccinated SC with a 0.5mL dose of varicella virus vaccine live. The nurse reported that the pt was previously vaccinated at another office and broke out with varicella lesions from head to toe. Unspecified medical attention was sought and no treatment was given. Subsequently, the pt recovered. A product quality complaint was not involved. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature decreased, Herpes zoster, Injection site rash, Tenderness
Clinical narrative: Information has been received from a nurse practitioner concerning a 15 month old female with no allergies, medical conditions, history of chickenpox, or recent exposure to chickenpox or herpes zoster who on 24Jun05 was vaccinated SC with a 0.5mL dose of varicella virus vaccine live (lot649269/0986P). there was no illness at the time of vaccination. The nurse reported that the pt was vaccinated at one year of age and a few months later, in 2005, broke out in a rash on the vaccinated leg. The rash was diagnosed as shingles. The pt was treated with oral acyclovir and recovered. A product quality complaint was not involved. Additional information has been received from the nurse practitioner who reported that in the pm of 06Sep05, the pt developed shingles on the right leg that were tender when touched. Her maximum axillary temperature was 97. The pt had no other systemic symptoms. She was given acyclovir and the rash resolved without any problem. The pt was recovered as of 10Sep05. No diagnostic lab tests including a direct fluorescent antibody or polymerase chain reaction were performed. The pt had no adverse events following prior vaccination. Additionally, it was noted that on 22Aug05, the pt was vaccinated with a fourth dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (crm197) (PREVNAR) (lotA94440F), a first dose of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot0992P), and a fourth dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid (lot C2220AA). No further information is expected.
Sex: U
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Information has been received from a physician's assistant concerning a school age pt who was vaccinated SC with a 0.5mL dose of varicella virus vaccine live. On 20Sep05, the pt came into the physician's office with about 15 chickenpox lesions. No treatment was given. At the time of the report, the pt had not recovered. A product quality complaint was not involved. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Pyrexia, Skin ulcer
Clinical narrative: Information has been received from a RN concerning her 4 yr old son with no allergies or medical history who a year ago in approx Sep 2004, and on 16Sep05 was vaccinated with a first and second dose of varicella virus vaccine live. There was no concomitant medication. On 16Sep05, the pt started to experience lesions on the head, face, ear, neck, back, arms and legs. He currently had many more than 50 lesions. He also had a slight fever the first few days. He was seen by a physician and treated with mupirocin (Bactroban) cream. At the time of the report, the pt had not recovered. A product quality complaint was not involved. Additional information has been requested.
Age: 45.0
Sex: F
Vaccine: VARCEL
Symptoms: Cellulitis, Feeling hot, Injection site erythema, Injection site reaction
Clinical narrative: Information has been received from a physician concerning a 44 yr old female with no allergies or medical conditions who on 10Jan03 was vaccinated SC in the right arm with a dose of varicella virus vaccine live (lot 643120/0505M). There was no illness at the time of vaccination. On 22Sep05, it was reported by the physician that 18 months ago, the pt developed a red area that looked like cellulitis at the site of vaccination. The pt was referred to an adult infectious disease specialist. A product quality complaint was not involved. Follow up information was received from a RN who reported that on 20Jan03, she received a phone call from the pt who reported a silver dollar sized area of redness at the injection site that was hot to the touch. Redness was increased and she was sent to an infectious disease specialist and treated with valacyclovir hydrochloride (Valtrex). There were no signs of systemic toxicity. It was unk if diagnostic lab tests were performed, but some may have been performed by the specialist. Subsequently, the pt recovered. No further information is expected.
Age: 1.29
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash papular, Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a health professional concerning an 8 yr old white female with congenital hypothyroidism who on 20Apr98 was vaccinated SC in the left arm with a 0.5ml first dose of varicella virus vaccine live (lot 624444/1322E). The pt had bilateral ACM at the time of vaccination, which is recurrent. On 22sep05 the pt presented with about 15-20 vesicular lesions on her torso, arms and face. No other symptoms were noted. At the time of this report the pt was recovering. No product quality complaint was involved. Medical attention was sought. Follow up information indicated that the pt did not have an adverse experience, but did come down with chickenpox. She had 15-20 erythematous vesicles and papules on face, trunk and arms. She never had a fever and there were no further lesions. The pt recovered on 28Sep05. Additional information is not expected.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a physician concerning a 24 month old female pt who in approx Sept 2004, at 12 months of age was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. This week, on approx 21Sep05 the pt experienced breakthrough varicella and came to the office. The child had a few lesions and no fever. It was a mild case and no treatment was given. At the time of the report the pt was recovering. The pt's twin brother (WAES0509USA04036) also developed breakthrough varicella after vaccination with varicella virus vaccine live.  Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Viral infection
Clinical narrative: Information has been received from a consumer concerning his approx 11 yr old daughter who was vaccinated with a dose of varicella virus vaccine live. In Sept 2005, the pt experienced chicken pox and went to visit a physician. The pt was not recovered. No product quality complaint was involved. No additional information was provided. Additional information is not available.
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a RN concerning an adult female with multiple sclerosis who was vaccinated with a second dose of varicella virus vaccine live. A titer was drawn which showed that the pt failed to seroconvert. It was unk if medical attention was sought. It was noted that the physician would determine whether to revaccinate. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a health professional concerning a 12 month old pt who in June 2005, was vaccinated with a dose of varicella virus vaccine live. It was reported that the baby returned the week of 12Sep05 with zoster on the forehead. It was noted that it was a very mild case with no fever. The physician started acyclovir and the zoster went away. Additional information has been requested.
Age: 11.0
Sex: U
Vaccine: VARCEL
Symptoms: Pyrexia, Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a physician concerning an 11 yr old pt who on 01Jun05 was vaccinated with a dose of varicella virus vaccine live (lot 647960/0070R). It was reported that on 10Jun05 the pt experienced breakthrough varicella with a rash, with less than 20 lesions, mostly facial and a fever. Subsequently, the pt recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a health professional concerning an 11 yr old female with no pertinent medical history and no drug reactions/allergies who on 25Jan99 was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. On 21Sep05 the pt developed a mild case of chickenpox. There were no lab diagnostic studies performed. The outcome was reported as not recovered. There was no further information available. There was no product quality complaint involved. Follow up information indicated that the pt presented to the office on 23Sep05 with complaints of a rash over her body. She was diagnosed with a mild case of varicella. Lesions were noted around her trunk, right ear lobe and scalp. The outcome was reported as recovered. No additional information is expected.
Age: 1.51
Sex: M
Vaccine: DTP, VARCEL
Symptoms: Drug ineffective, Rash vesicular, Viral infection
Clinical narrative: Information has been received from a physician and a woman in the physician's office concerning a 10 yr old black male student who on 03Mar97, at 18 months of age, was vaccinated SC with the first 0.5mL dose of varicella virus vaccine live (lot617913/0778D). Concomitant vaccinations on that same day included an IM fourth dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid (lot438-064). Illness at the time of vaccination included respiratory allergies. Other comcomitant therapy included chlorpheniramine maleate (+) phenylephrine HC1 (+) phenylpropanolamine HC1 (+) phenyltoloxamine citrate (Naldecon Pediatric Syrup). The physician reported that on 13Sep05, the pt developed breakthrough chickenpox. It was noted that by 14Sep05, the pt had multiple box described as alot of small bumps. In Sept 2005, the pt recovered from breakthrough chickenpox. No further information is available.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a pharmacist concerning a 12 month old female who in August 2005 was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck). Three days later the patient developed a mild case of varicella which resolved spontaneously. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 1.04
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a health professional concerning a 36 month old female who on 09-OCT-2003 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (Lot# "C1063M"). There was no concomitant medication. It was reported that on 26-SEP-2005 the patient experienced a breakthrough case of varicella of 50 lesions or less. It was reported that the patient was recovering. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 17.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a nurse concerning a 17 year old male patient who was vaccinated with varicella virus vaccine live (Oka/Merck). Subsequently the patient experienced breakthrough varicella. There was no further information available regarding the adverse event or the patient's outcome. There was no product quality complaint reported.
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a physician concerning a healthy female patient who in 1995 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). "Earlier this year", in 2005, the patient experienced full blown chicken pox. Subsequently, the patient recovered from chicken pox. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: HBHEPB, VARCEL
Symptoms: Rash erythematous, Rash vesicular
Clinical narrative: Rash Erythematous; Rash Vesicular Information has been received from a physician concerning a 12 month old female with no known allergies or medical conditions who on 04-MAY-2004 was vaccinated SC in the right arm with a first dose of varicella virus vaccine live (Oka/Merck) (Lot# 648047-1346N). Concomitant therapy included a third dose IM in the right arm with HIB conj-hepatitis B vaccine (MSD) (lot#647167/1113N). There was no illness at the time of vaccination. On 06-JUN-2005 the patient experienced an erythematous vesicular rash and no other symptoms. The rash resolved with supportive care. No lab tests were done.  The patient's brother (WAES 0509USA03955) had similar symptoms after vaccination with varicella virus vaccine live (Oka/Merck). Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Pruritus, Rash erythematous, Rash vesicular
Clinical narrative: Info has been received from a physician concerning a 5 year old male with attention deficit/hyperactivity disorder and mild asthma who on 9/5/03 was vaccinated, SC in the left arm with a 1st dose of varicella virus vaccine live (lot 644558/1156M). Concomitant therapy included a 2nd dose in the left arm of MMRII (lot 644577/1037M), a 5th dose in the right arm of Tripedia (lot C1387AA) and a 4th dose in the right arm of IPOL (lot W0750). On 6/6/05, the pt experienced an erythematous vesicular rash that was itchy. It was noted that it was in clusters. Subsequently, the pt recovered with supportive care. There were no labs done. The pt's sister had a similar reaction after vaccination with varicella virus vaccine live. Additional info is not expected.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a physician concerning a 24 month old male pt who in approx. September 2004, at 12 months of age, was vaccinated, SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. "This week", on approx. 9/21/05, the pt experienced breakthrough varicella and came to the office. The child had a few lesions and no fever. It was a mild case and no treatment was given. At the time of the report, the pt was recovering. The pt's twin sister also developed breakthrough varicella after vaccination with varicella virus vaccine live. Additional info has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Hypersensitivity, Rash
Clinical narrative: Info has been received from a nurse concerning a pt with egg allergy who was vaccinated with varicella virus vaccine live. The nurse reported that the pt experienced an allergic reaction to the varicella virus vaccine live, in the form of a rash. The adverse event improved and the pt has recovered. No additional info regarding the adverse event was available. There was no product quality complaint reported. Follow-up info was received from an RN who reported that the pt is unknown to them. The pt sought unspecified medical attention. No additional info is expected.
Age: 1.21
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Injection site reaction, Pyrexia
Clinical narrative: Info has been received from a nurse, who is also the mother concerning her 18 month old daughter, who on an unknown date in August 2005 was vaccinated with a dose of varicella virus vaccine live. The mother reported that her daughter had a reaction to the recent vaccination with varicella virus vaccine live, which she described as a fever of 104 degrees Fahrenheit, a pox-like rash, and a severe injection site reaction. It was reported that the adverse event improved and the pt recovered on an unknown date. There was no product quality complaint reported. The pt sought unspecified medical attention. Additional info has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Infection, Infection transmission via personal contact
Clinical narrative: Info has been received from a nurse concerning a 24 month old female who was vaccinated at 12 months of age with a dose of varicella virus vaccine live. On 9/6/05, the pt experienced a severe case of chickenpox. Subsequently, the pt recovered. It was noted that the father had developed shingles that required an ER visit prior to the child's outbreak. Unspecified medical attention was sought. No product quality complaint was involved. The pt's brother also developed chicken pox after vaccination with varicella virus vaccine live. Additional info has been requested.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Infection, Infection transmission via personal contact
Clinical narrative: Info has been received from a physician concerning a 5 year old female who on approximately 8/27/05, (one month prior to the report) was vaccinated with a 0.5ml dose of varicella virus vaccine live. It was reported that on month prior to this report, in August 2005, the pt developed 15-20 lesions. Unspecified medical attention was sought. Subsequently, the pt recovered. No product quality complaint was involved. The physician also reported that the pt's 1 year old sibling who has not received varicella virus vaccine live developed chickenpox. Additional info has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Pyrexia
Clinical narrative: Info has been received from an RN concerning her 2 or 3 year old daughter who in 1998 was vaccinated, SC, with a 1st 0.5ml dose of varicella virus vaccine live. Concomitant therapy included acetaminophen (Tylenol). In approximately 2001 or 2002, the pt experienced breakthrough chickenpox. The case was considered mild with 20-25 lesions and involved a low-grade fever. Unspecified medical attention was sought. Subsequently, the pt recovered. No product quality complaint was involved. Additional info has been requested.
Sex: U
Vaccine: MEA
Symptoms: Hypersensitivity
Clinical narrative: Info has been received from a physician concerning a pt with an egg allergy who was vaccinated, SC, with a 0.5 ml dose of varicella virus vaccine live. Subsequently, the pt experienced an allergic reaction following vaccination. Unspecified medical attention was sought. It was reported that the pt recovered. No further info was available. No product quality complaint was involved. Additional info has been requested.
Age: 1.01
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from an NP concerning a 6 year old male who on 9/28/1999 was vaccinated with a dose of varicella virus vaccine live (lot 631071/1002J). On 8/29/05, the pt experienced breakthrough chickenpox, less than 50 lesions. Unspecified medical attention was sought. It was reported that the pt recovered from the breakthrough chickenpox. No product quality complaint was involved. The NP also reported that the pt's brother also experienced breakthrough chickenpox after being vaccinated with varicella vaccine live. Additional info has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a physician concerning a 4 year old female who on 5/14/02 was vaccinated with a dose of varicella virus vaccine live (lot 641266/1293L). On 9/26/05, the pt developed mild breakthrough chickenpox characterized by approximately 10 lesions. Unspecified medical attention was sought. A product quality complaint was not involved. Additional info has been requested.
Age: 1.03
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Pruritus
Clinical narrative: Info has been received from a physician concerning a 9 year old Hispanic female with no allergies or medical conditions who on 2/21/97 was vaccinated, SC, with a 1st dose of 0.5ml dose of varicella virus vaccine live. There was no illness at the time of vaccination. On approximately 9/21/05, 1 week ago, the pt experienced breakthrough chickenpox with approximately 50 lesions. Unspecified medical attention was sought. No product quality complaint was involved. No additional info was provided. Follow-up info indicated that the pt did not experience an adverse event. It was noted that on 10/22/05, the pt experienced a case of vaccine failure, developed acute varicella "attenuated" with definite papulomacules, but without vesicles. She had significant pruritus and recovered on 11/2/05. Additional info is not expected.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Skin ulcer
Clinical narrative: Varicella Information has been received from a registered nurse concerning a 12 year old female patient who was vaccinated with varicella virus vaccine live (Oka/Merck) and experienced breakthrough chickenpox with less that 50 lesions. No further information was available regarding the patient's adverse event or outcome. There was no product quality complaint reported.
Sex: U
Vaccine: VARCEL
Symptoms: Rash maculo-papular, Skin ulcer
Clinical narrative: Varicella Information has been received from a physician concerning a patient who was vaccinated with varicella virus vaccine live (Oka/Merck). In September 2005, the patient developed breakthrough, which was described as a mild case with less than 30 lesions. The lesions were reported as maculopapular in nature. The adverse event improved and the patient is recovering. No further information was available regarding the adverse event. There was no product quality complaint.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Hypersensitivity, Nasal congestion, Pyrexia, Rash, Rhinitis allergic
Clinical narrative: Information has been received from an office manager concerning an 8-year-old male student with allergies to ragweed, trees, dust mites, grassweed, cats and allergic rhinitis who on 05-Mar-1998 was vaccinated subcutaneously at another medical facility with a 0.5 ml dose of dose of varicella virus vaccine live.  There was no illness at the time of the vaccination.  On 29-Sep-2005 at 11:00 the patient presented to the physician's office with chickenpox characterized by 30-40 "bumps on chest, face, back"; a low grade fever; and nasal congestion.  The symptoms developed approximately 14 days after exposure to a child with chickenpox.  No treatment was given.  The reporter reported the patient's status as recovered as of 02-Oct-2005.  No product quality complaint was involved.  Additional information has been requested.
Age: 1.02
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from an office manager concerning an 8-year-old male student with allergies to ragweed, trees, dust mites, grassweed, cats and allergic rhinitis who on 05-Mar-1998 was vaccinated subcutaneously at another medical facility with a 0.5 ml dose of dose of varicella virus vaccine live.  There was no illness at the time of the vaccination.  On 29-Sep-2005 at 11:00 the patient presented to the physician's office with chickenpox characterized by 30-40 "bumps on chest, face, back"; a low grade fever; and nasal congestion.  The symptoms developed approximately 14 days after exposure to a child with chickenpox.  No treatment was given.  The reporter reported the patient's status as recovered as of 02-Oct-2005.  No product quality complaint was involved.  Additional information has been requested.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Hypersensitivity, Viral infection
Clinical narrative: Information has been received from a physician concerning a 10-year-old male with seasonal allergies who on 08-Aug-2005 was vaccinated with a dose of varicella vaccine live.  Concomitant therapy included budesonide (Rhincort).  The physician reported that on 23-Aug-2005, the patient developed chickenpox.  Unspecified medical attention was sought and the patient subsequently recovered from the chickenpox.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash maculo-papular, Viral infection
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with varicella virus vaccine live.  In September 2005, the patient developed breakthrough, which was described as a mild case with less than 30 lesions.  The lesions were reported as maculopapular in nature.  The adverse event was improved and the patient is recovering.  No further information was available regarding the adverse event.  There was no product quality complaint reported  The patient sought unspecified medical attention.  Additional information has been requested.  The physician reported that the patient's sibling also developed breakthrough following vaccination with varicella virus vaccine live.
Sex: U
Vaccine: VARCEL
Symptoms: Hypersensitivity
Clinical narrative: Info has been received from a physician concerning one pt with an egg allergy who was vaccinated, SC, with a 0.5 ml dose of varicella virus vaccine live. Subsequently, the pt experienced an allergic reaction following vaccination. Unspecified medical attention was sought. The pt required hospitalization. It was reported that the pt recovered. No further info was available. No product quality complaint was involved. Additional info is not expected.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Information has been received from a nurse practitioner (N.P.) concerning an 8-year-old male who on 27-Oct-1997 was vaccinated with a dose of varicella virus vaccine live.  On 13-Aug-2005 the patient experienced breakthrough chickenpox, less than 50 lesions.  Unspecified medical attention was sought.  It was reported that the patient recovered from the breakthrough chickenpox.  No product quality complaint was involved.    The nurse practitioner also reported that the patient's brother also experienced breakthrough chickenpox after being vaccinated with varicella virus vaccine live.  Additional information has been requested.
Age: 1.03
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Information has been received from a nurse practitioner (NP) concerning a 12-month-old female with no medical history who on 12-SEP-2005 was vaccinated in the right thigh with the first dose of varicella virus vaccine live. Concomitant vaccinations on that day included a first dose in the left thigh of mmr (Lot #648462/0044P and the fourth dose in the left thigh of Prevnar (Lot #974404H). There was no illness at the time of vaccination. The NP reported that on 29-SEP-2005, the patient developed a varicella-like rash with an erythematous base on her head, face, neck, and back. On 30-SEP-2005, the patient was seen in the physician's office. On 07-OCT-2005, the patient's varicella-like rash resolved. Additional information is not expected.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Rash maculo-papular, Viral infection
Clinical narrative: Information has been received from a physician concerning a 10-year-old male who on 18-DEC-1996 was vaccinated with varicella virus vaccine live. On 25-SEP-2005 the patient developed a papular lesion believed to be chicken pox. There was a known exposure to the disease in school. The lesions were on her face, trunk, back and extremities. The patient was put on gentamicin. The adverse event improved and the patient is recovering. There was no product quality complaint reported. Additional information received on 18-OCT-2005 reported that the patient had chickenpox after having received varicella virus vaccine live years ago. No further information is expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Drug ineffective, Viral infection
Clinical narrative: Information has been received from a nurse in a physician's office concerning a 40-month-old white male with no known medical history or allergies who on 15-MAY-2003 was vaccinated in the left leg with a dose of varicella virus vaccine live (lot # 644250/1153M). There was no illness at the time of vaccination. On 20-SEP-2005 the patient developed an unusual case of breakthrough, which was described as 20-25 initial lesions which crusted over. On 29-SEP-2005 new lesions developed and "now" (30-SEP-2005) the patient has more than 50 lesions. No fever was present. The patient sought unspecified medical attention. The adverse event did not improve and the patient had not recovered. No further information was available regarding the adverse event. There was no product quality complaint reported. Follow-up information from the physician indicated that on 14-SEP-2005 the patient developed greater than 50 fluid filled vesicles with new lesions occurring over a two week period. The lesions were mostly located on the right torso with a few scattered on his arms, legs and back. All were scabbed over. Additional information is not expected.
Age: 15.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Information has been received from a physician concerning a 15-year-old male with no pertinent medical history who on approximately 15-SEP-2005 was vaccinated with a dose of varicella virus vaccine live. On approximately 22-SEP-2005, 7 days post vaccination, the patient developed a varicella-like rash on his arms and legs. The lesions were vesicular in nature and no fever was present. It was reported that the patient recovered. Unspecified  medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Information has been received from a health professional concerning a 9-year-old white male, with no known drug allergies, who on 13-AUG-1999 was vaccinated with a subcutaneous first dose in the left thigh of varicella virus vaccine live (Lot# 630675/0424J). There was no illness at the time of vaccination and there were no adverse events following prior vaccination. It was report that, on 26-SEP-2005 at 11:26 AM, the patient's mother called the office and stated that the child had broken out with about 10 lesions on his back and 1 on his thigh, which the patient's mother thought was chickenpox. It was noted that there were no ill effects to the child. The patient recovered on 26-SEP-2005. There were no laboratory or diagnostic tests performed. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a physician concerning an 11 yr old male who was vaccinated with a dose of varicella virus vaccine live. On 13Jun05 the pt presented with breakthrough varicella, with less than 50 lesions, mostly crusted and scattered on the body. The pt had no fever, and no treatment was necessary. Subsequently, the pt recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 35.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a pharmacist concerning a 35 yr old adult white male with no pre-existing allergies, birth defects, or medical conditions who on 20May05 at 13:55 9lot 649644/1050P) and 19Jul05 (lot651280/0408R) was vaccinated SC in the right deltoid with the first and second 0.5mL doses of varicella virus vaccine live. There was no illness at the time of vaccination. On 22Sep05 at 16:51, the pt had varicella titers drawn and the results did not show seroconversion. Unspecified medical attention was sought. There was no product quality complaint. No other information was available. Follow up information indicated that the pt had a varicella zoster IgG Ab done to check for antibody status after 2 doses of varicella virus vaccine live and did not develop antibodies. There were no adverse events following prior vaccinations. No additional information is expected.
Age: 1.99
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Myalgia, Pruritus, Rash vesicular, Skin ulcer
Clinical narrative: Information has been received from a health professional concerning a 9 yr old male described as healthy with no known medical history or allergies who on 07OCT97 was vaccinated with a 0.5mL SC second dose of varicella virus vaccine live (lot623645/0696E). There was no concomitant medication. On 16Sep05 the pt developed a breakthrough case of varicella of about 20 lesions with itching. The pt's chickenpox was also described as scattered small spots, approx 25 lesions, with itching and body aches. Unspecified medical attention was sought and diphenhydramine hydrochloride (Benadryl) was prescribed for the itching. At the time of the report the pt had recovered. There was no product quality complaint involved. Additional information is not expected.
Age: 1.99
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a 9 yr old male described as healthy with no known medical history or allergies who on 07OCT97 was vaccinated with a 0.5mL SC second dose of varicella virus vaccine live (lot623645/0696E). There was no concomitant medication. On 16Sep05 the pt developed a breakthrough case of varicella of about 20 lesions with itching. The pt's chickenpox was also described as scattered small spots, approx 25 lesions, with itching and body aches. Unspecified medical attention was sought and diphenhydramine hydrochloride (Benadryl) was prescribed for the itching. At the time of the report the pt had recovered. There was no product quality complaint involved. Additional information is not expected.
Age: 0.99
Sex: M
Vaccine: IPV, VARCEL
Symptoms: Drug ineffective, Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a physician concerning a 5 yr old southeast Asian male with mild sensorineural hearing loss and no known drug allergies, who on 09Jan01 at 10:00AM was vaccinated with a first dose in the left thigh of varicella virus vaccine live (lot634478/0091K). Concomitant therapy included tuberculin purified protein derivative (PPD tine test) and poliovirus vaccine. There was no illness at the time of vaccination, no adverse events following prior vaccination, and no other concomitant medications. On 20Sep05 the pt experienced breakthrough varicella with approx 100 lesions. Subsequently, the pt recovered on 27Sep05. There were no lab or diagnostic tests performed. Follow up information from a health professional indicated that the pt's parent scheduled an appt to evaluate the rash that had a one week duration. It was noted that there were no complications. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: DTAP, HEP, IPV, MMR, VARCEL
Symptoms: Dermatitis, Pruritus, Rash, Rash papular, Rash vesicular
Clinical narrative: Rash Vesicular; Pruritus; Acarodermatitis; Vomiting Information has been received from a registered nurse (RN) concerning a 6 year old healthy male with no allergies or medical history who on 26-SEP-2005 was vaccinated SC in the left arm with a dose of varicella virus vaccine live (Oka/Merck) (Lot#651176/0424R). Concomitant vaccinations on that same day included the third IM dose in the right arm of hepatitis B virus vaccine rHBsAG (yeast) (MSD) (Lot#650044/0004R). An SC dose in the left arm of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD) (Lot#647563/0578R), an IM dose in the right arm of diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (DAPTACEL) (Lot#C2254AA) and an SC dose in the right arm of poliovirus vaccine inactivated (Vero) (Lot#X0324). The RN reported that on 04-OCT-2005, the patient developed an itchy papulo-vesicular rash on his chest, abdomen and legs. The patient was also noted to have vomited once. The patient was seen in a physician's office and was treated with diphenhydramine HCL (Benadryl). No laboratory/diagnostic tests were performed. On 02-DEC-2005, the patient was again seen in the physician's office with rash that was subsequently diagnoses as scabies. The patient was treated with Permethrin (ELIMITE CREAM). At the time of this report the outcome was unknown. The RN felt that the patient's itchy papulo-vesicular rash and vomiting were not due to vaccination with varicella virus vaccine live (Oka/Merck). Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: DTAP, HEP, IPV, MMR, VARCEL
Symptoms: Vomiting
Clinical narrative: Rash Vesicular; Pruritus; Acarodermatitis; Vomiting Information has been received from a registered nurse (RN) concerning a 6 year old healthy male with no allergies or medical history who on 26-SEP-2005 was vaccinated SC in the left arm with a dose of varicella virus vaccine live (Oka/Merck) (Lot#651176/0424R). Concomitant vaccinations on that same day included the third IM dose in the right arm of hepatitis B virus vaccine rHBsAG (yeast) (MSD) (Lot#650044/0004R). An SC dose in the left arm of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD) (Lot#647563/0578R), an IM dose in the right arm of diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (DAPTACEL) (Lot#C2254AA) and an SC dose in the right arm of poliovirus vaccine inactivated (Vero) (Lot#X0324). The RN reported that on 04-OCT-2005, the patient developed an itchy papulo-vesicular rash on his chest, abdomen and legs. The patient was also noted to have vomited once. The patient was seen in a physician's office and was treated with diphenhydramine HCL (Benadryl). No laboratory/diagnostic tests were performed. On 02-DEC-2005, the patient was again seen in the physician's office with rash that was subsequently diagnoses as scabies. The patient was treated with Permethrin (ELIMITE CREAM). At the time of this report the outcome was unknown. The RN felt that the patient's itchy papulo-vesicular rash and vomiting were not due to vaccination with varicella virus vaccine live (Oka/Merck). Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Rash Vesicular Information has been received from a health professional concerning a female patient with no medical history and no allergies who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. It was reported that approximately six weeks after receiving varicella virus vaccine live (Oka/Merck) the patient developed what appeared to be a varicella type rash that was described as 10 small vesicular lesions on her legs, chest and arms. There were no other complaints. The patient was seen on 05-OCT-2005. No treatment was ordered. There were no laboratory or diagnostic tests performed. It was noted that lesions were starting to dry up and that the patient was recovering. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash, Rash maculo-papular
Clinical narrative: Rash maculopapular; Pyrexia Information has been received from a health professional concerning a 25 month old white male with no known medical history or allergies who the morning of 12-SEP-2005 was vaccinated with 0.5ml SC first dose of varicella virus vaccine live (Oka/Merck) (lot#651047/0326R). Suspect vaccination that same morning included a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot#649518/0154R). Suspect therapy included amoxicillin 250/5ml BID x 10 days which started on 27-SEP-2005. There was no illness at the time of vaccination. On 02-OCT-2005 (previously reported as approximately 03-OCT-2005) the patient developed a generalized, scattered red rash and a fever of 103 F. The fever was later described as 103.4F for three days on and off. The rash was later described as a maculopapular rash that was spreading to legs and thighs. It was noted that the diagnosis was to "rule out vaccine associated reaction vs. amoxicillin reaction". Unspecified medical attention was sought. The patient recovered on an unspecified date. there was no product quality complaint involved.  Additional information is not expected. Body temp 10/02/05 103.4F.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site reaction, Skin ulcer
Clinical narrative: Skin Lesion Information has been received from a health care professional concerning a 12 month old female with no pertinent medical history or allergies who on approximately 26-SEP-2005, 1 1/2 weeks ago was vaccinated SC in the thigh with a 0.5ml dose of varicella virus vaccine live (Oka/Merck). On 05-OCT-2005 the patient presented to the clinic with an"oozing lesion at the injection site". It was unknown what treatment was given. No product quality complaint was involved. No further information was available. Follow up information from the health professional indicated that the child never came into the office to have a reaction check. The reporter explained to the mother that if the child got worse to come into the office. She never got a follow up call so she is assuming the child got better over the next couple of days. This is all the information available. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin ulcer
Clinical narrative: Varicella Information has been received from a physician concerning a 47 month old male who on 31-COT-2002 was vaccinated SC with a 0.5ml dose of varicella virus vaccine live (Oka/Merck). On 01-OCT-2005, the patient developed break through chickenpox. He had approximately 10 lesions and did not have a fever. Unspecified medical attention was sought. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested. Body temp 10/01/05 afebrile.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Skin ulcer
Clinical narrative: Varicella Information has been received from a health professional concerning her daughter a 5 year old female who on 14-JUN-2002 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On -5-OCT-2005 the patient developed a mild case of breakthrough. The symptoms began with a temperature of 100.1F on 05-OCT-2005 and 10 lesions that appeared on 06-OCT-2005. At the time of the report the patient had not yet recovered. Unspecified medical attention was south. There was no product quality complaint involved. Additional information has been requested. Body temp 10/05/05 100.1F
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a physician concerning a child patient who was vaccinated SC with a 0.5ml dose of varicella virus vaccine live (Oka/Merck). "Recently" in approximately October 2005 the patient developed wild type varicella. The case was neither mild, nor was it severe. Unspecified medical attention was sought. At the time of the report the patient's status was unknown. There was no product quality complaint involved.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Herpes Zoster Information has been received from a registered nurse (RN) concerning a 10 year old female who in 1998 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The RN reported that in early October 2005, the patient developed lesions which followed a dermatome on the head, ear and neck. Unspecified medical attention was sought. A diagnosis of herpes zoster was made and the patient was treated with acyclovir. At the time of this report, the patient's herpes zoster persisted. Additional information has been requested.